MAPPI: Market Access Potential and Price Index Tool

  • Evaluates the Market Access Potential of Early Stage Assets (Prior to Phase III)
  • Provides a global answer by focusing on payer value elements found across health care systems
    • Developed with Payers and validated through more than 30 products
    • Mimics Health Technology Assessment bodies and payers’ evaluation processes
  • Questions and/or calls attention on critical NPV assumptions: price, reimbursed population definition, development spent, time to reimbursement
  • Results are not stored and remain completely confidential

Completing the data fields below is optional, data is only used for outcome pages or for contact information if there is a wish to be on the groupH mailing list. To use the tool, click below and simply complete the evaluation process for your product:
    If you want the product and indication to appear on outcome pages